Drug Shortage Report for HULIO
| Report ID | 174128 |
| Drug Identification Number | 02502402 |
| Brand name | HULIO |
| Common or Proper name | ADALIMUMAB |
| Company Name | BIOSIMILAR COLLABORATIONS IRELAND LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ADALIMUMAB |
| Strength(s) | 40MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 2 x 0.8mL sterile solution subcutaneous injection (PEN) (40mg/0.8mL) |
| ATC code | L04AB |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-10-31 |
| Estimated end date | 2022-11-21 |
| Actual end date | 2022-11-21 |
| Shortage status | Resolved |
| Updated date | 2022-11-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | GRANGE PARADE, BALDOYLE INDUSTRIAL ESTATE, DUBLIN 13 DUBLIN, -- IRELAND D13R20R |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-11-22 | French | Compare |
| v7 | 2022-11-22 | English | Compare |
| v6 | 2022-11-22 | French | Compare |
| v5 | 2022-11-22 | English | Compare |
| v4 | 2022-11-17 | French | Compare |
| v3 | 2022-11-17 | English | Compare |
| v2 | 2022-11-09 | French | Compare |
| v1 | 2022-11-09 | English | Compare |
Showing 1 to 8 of 8